Is Alnylam Pharmaceuticals, Inc. (ALNY) a Buy, Sell, or Hold?
NASDAQ : ALNY
Alnylam Pharmaceuticals, Inc.
$269.5665 USD
-$13.58 (-4.8%)
- Volume
- 574.6K
- Average Volume
- 1.27M
- Market Capitalization
- $35.99B
- P/E Ratio
- 61.83
- Dividend Yield
- 0.00%
- Price Target
- $436.50
- Year High
- $495.55
- Year Low
- $269.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
ALNY vs. The Competition
| Properties | ALNY | ARGX | BDX | CAH |
|---|---|---|---|---|
| Market Cap | $35.99B | $53.59B | $56.99B | $53.65B |
| Shares Outstanding | $133.51M | $62.56M | $362.3M | $234.21M |
| P/E Ratio | 61.83 | 48.17 | 39.82 | 34.92 |
| EPS | 4.34 | 18.38 | 4.06 | 6.63 |
| Day Low | 269.28 | 840.7 | 157.25 | 228.99 |
| Day High | 284.3595 | 860.54 | 163.14 | 233.2 |
| Year Low | 269.28 | 560.908 | 127.58648 | 137.75 |
| Year High | 495.55 | 953.58 | 187.35 | 243.21 |
| Average Price 50 | 294.947 | 854.716 | 148.65 | 213.5808 |
| Average Price 200 | 360.00366 | 824.82043 | 154.49129 | 204.77106 |
| Volume | 574.6K | 174.5K | 1.1M | 760.48K |
| Average Volume | - | - | - | - |